Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GUSBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAICS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NETO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPH7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DSTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX7C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHMP2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIOK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DSTYK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LZTFL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERP44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FASTKD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMM8B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABL6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on